- call +1-201-465-4211
- email sales@mrinsights.biz
Dermatology is a field of medicine that is engaged in the diagnosis, prevention, and treatment of various skin, nails, hair diseases, pigmentation, acne, wrinkles, psoriasis, and others.
Scope of the Report:
This report focuses on the Dermatological Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Different techniques are used in dermatology such as topical & systemic medications, laser therapy, radio therapy, photodynamic therapy, vitiligo surgery, dermatological surgery, and others.
The worldwide market for Dermatological Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Bayer
Johnson & Johnson
Pfizer
Novartis
GlaxoSmithKline
AstraZeneca
Galderma
Amgen
AbbVie
Merck
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Prescription-Based Drugs
Over-the-Counter Drugs
Market Segment by Applications, can be divided into
Acne
Skin Infections
Psoriasis
Dermatitis Drugs
Other
There are 15 Chapters to deeply display the global Dermatological Drugs market.
Chapter 1, to describe Dermatological Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Dermatological Drugs, with sales, revenue, and price of Dermatological Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Dermatological Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Dermatological Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Dermatological Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Dermatological Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Prescription-Based Drugs
1.2.2 Over-the-Counter Drugs
1.3 Market Analysis by Applications
1.3.1 Acne
1.3.2 Skin Infections
1.3.3 Psoriasis
1.3.4 Dermatitis Drugs
1.3.5 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Business Overview
2.1.2 Dermatological Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bayer Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Johnson & Johnson
2.2.1 Business Overview
2.2.2 Dermatological Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Johnson & Johnson Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Pfizer
2.3.1 Business Overview
2.3.2 Dermatological Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Pfizer Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Novartis
2.4.1 Business Overview
2.4.2 Dermatological Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Novartis Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 GlaxoSmithKline
2.5.1 Business Overview
2.5.2 Dermatological Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 GlaxoSmithKline Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 AstraZeneca
2.6.1 Business Overview
2.6.2 Dermatological Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 AstraZeneca Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Galderma
2.7.1 Business Overview
2.7.2 Dermatological Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Galderma Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Amgen
2.8.1 Business Overview
2.8.2 Dermatological Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Amgen Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 AbbVie
2.9.1 Business Overview
2.9.2 Dermatological Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 AbbVie Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Merck
2.10.1 Business Overview
2.10.2 Dermatological Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Merck Dermatological Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Dermatological Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Dermatological Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Dermatological Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Dermatological Drugs Manufacturer Market Share in 2017
3.3.2 Top 6 Dermatological Drugs Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Dermatological Drugs Market Analysis by Regions
4.1 Global Dermatological Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Dermatological Drugs Sales and Market Share by Regions (2013-2018)
4.1.2 Global Dermatological Drugs Revenue and Market Share by Regions (2013-2018)
4.2 North America Dermatological Drugs Sales and Growth Rate (2013-2018)
4.3 Europe Dermatological Drugs Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Dermatological Drugs Sales and Growth Rate (2013-2018)
4.5 South America Dermatological Drugs Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Dermatological Drugs Sales and Growth Rate (2013-2018)
5 North America Dermatological Drugs by Countries
5.1 North America Dermatological Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Dermatological Drugs Sales and Market Share by Countries (2013-2018)
5.1.2 North America Dermatological Drugs Revenue and Market Share by Countries (2013-2018)
5.2 United States Dermatological Drugs Sales and Growth Rate (2013-2018)
5.3 Canada Dermatological Drugs Sales and Growth Rate (2013-2018)
5.4 Mexico Dermatological Drugs Sales and Growth Rate (2013-2018)
6 Europe Dermatological Drugs by Countries
6.1 Europe Dermatological Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Dermatological Drugs Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Dermatological Drugs Revenue and Market Share by Countries (2013-2018)
6.2 Germany Dermatological Drugs Sales and Growth Rate (2013-2018)
6.3 UK Dermatological Drugs Sales and Growth Rate (2013-2018)
6.4 France Dermatological Drugs Sales and Growth Rate (2013-2018)
6.5 Russia Dermatological Drugs Sales and Growth Rate (2013-2018)
6.6 Italy Dermatological Drugs Sales and Growth Rate (2013-2018)
7 Asia-Pacific Dermatological Drugs by Countries
7.1 Asia-Pacific Dermatological Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Dermatological Drugs Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Dermatological Drugs Revenue and Market Share by Countries (2013-2018)
7.2 China Dermatological Drugs Sales and Growth Rate (2013-2018)
7.3 Japan Dermatological Drugs Sales and Growth Rate (2013-2018)
7.4 Korea Dermatological Drugs Sales and Growth Rate (2013-2018)
7.5 India Dermatological Drugs Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Dermatological Drugs Sales and Growth Rate (2013-2018)
8 South America Dermatological Drugs by Countries
8.1 South America Dermatological Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Dermatological Drugs Sales and Market Share by Countries (2013-2018)
8.1.2 South America Dermatological Drugs Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Dermatological Drugs Sales and Growth Rate (2013-2018)
8.3 Argentina Dermatological Drugs Sales and Growth Rate (2013-2018)
8.4 Colombia Dermatological Drugs Sales and Growth Rate (2013-2018)
9 Middle East and Africa Dermatological Drugs by Countries
9.1 Middle East and Africa Dermatological Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Dermatological Drugs Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Dermatological Drugs Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Dermatological Drugs Sales and Growth Rate (2013-2018)
9.3 UAE Dermatological Drugs Sales and Growth Rate (2013-2018)
9.4 Egypt Dermatological Drugs Sales and Growth Rate (2013-2018)
9.5 Nigeria Dermatological Drugs Sales and Growth Rate (2013-2018)
9.6 South Africa Dermatological Drugs Sales and Growth Rate (2013-2018)
10 Global Dermatological Drugs Market Segment by Type
10.1 Global Dermatological Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Dermatological Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Dermatological Drugs Revenue and Market Share by Type (2013-2018)
10.2 Prescription-Based Drugs Sales Growth and Price
10.2.1 Global Prescription-Based Drugs Sales Growth (2013-2018)
10.2.2 Global Prescription-Based Drugs Price (2013-2018)
10.3 Over-the-Counter Drugs Sales Growth and Price
10.3.1 Global Over-the-Counter Drugs Sales Growth (2013-2018)
10.3.2 Global Over-the-Counter Drugs Price (2013-2018)
11 Global Dermatological Drugs Market Segment by Application
11.1 Global Dermatological Drugs Sales Market Share by Application (2013-2018)
11.2 Acne Sales Growth (2013-2018)
11.3 Skin Infections Sales Growth (2013-2018)
11.4 Psoriasis Sales Growth (2013-2018)
11.5 Dermatitis Drugs Sales Growth (2013-2018)
11.6 Other Sales Growth (2013-2018)
12 Dermatological Drugs Market Forecast (2018-2023)
12.1 Global Dermatological Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Dermatological Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Dermatological Drugs Market Forecast (2018-2023)
12.2.2 Europe Dermatological Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Dermatological Drugs Market Forecast (2018-2023)
12.2.4 South America Dermatological Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Dermatological Drugs Market Forecast (2018-2023)
12.3 Dermatological Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Dermatological Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Dermatological Drugs Market Share Forecast by Type (2018-2023)
12.4 Dermatological Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Dermatological Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Dermatological Drugs Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Dermatological Drugs Picture
Table Product Specifications of Dermatological Drugs
Figure Global Sales Market Share of Dermatological Drugs by Types in 2017
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
